All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Denosumab-related osteonecrosis of the external auditory canal-benefit of the early surgical management

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F24%3A00077948" target="_blank" >RIV/65269705:_____/24:00077948 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216224:14110/24:00134971 RIV/00098892:_____/24:10157555

  • Result on the web

    <a href="https://journals.sagepub.com/doi/10.1177/01455613211053389" target="_blank" >https://journals.sagepub.com/doi/10.1177/01455613211053389</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1177/01455613211053389" target="_blank" >10.1177/01455613211053389</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Denosumab-related osteonecrosis of the external auditory canal-benefit of the early surgical management

  • Original language description

    Background: Antiresorptive drugs are widely used to reduce bone mineral loss in patients with osteoporosis and to prevent skeletal-related events in patients with metastatic cancers and multiple myeloma (MM). Both the bisphosphonates (BP) and denosumab typically used in this indication were shown to be effective and relatively safe. Obviously, this medication could have some adverse effects; one of them is osteonecrosis of the external auditory canal. Only sporadic cases of external auditory canal osteonecrosis have been published yet. Here, we provide a case of denosumab-related osteonecrosis of the external auditory canal successfully treated surgically in the early stage of the disease. Case report: A 68-year-old patient with breast cancer underwent comprehensive oncological treatment, including denosumab administration. She was diagnosed with osteonecroses in the jaw and ear canal. The necrotic bones in both regions were resected with primary wound closure. Both affected sites healed well with no signs of necrosis recurrence. Conclusions: Osteonecrosis of the external auditory canal is a rare but probably underdiagnosed complication of antiresorptive medication. It has a negative impact on patient quality of life if left untreated. Early surgical treatment appears to be effective. The authors highlight several similarities with medication-related osteonecrosis of the jaw. Therefore, an analogous disease staging and treatment rationale is suggested.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30206 - Otorhinolaryngology

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2024

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    ENT-Ear Nose &amp; Throat Journal

  • ISSN

    0145-5613

  • e-ISSN

    1942-7522

  • Volume of the periodical

    103

  • Issue of the periodical within the volume

    5

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    5

  • Pages from-to

    277-281

  • UT code for WoS article

    000710707200001

  • EID of the result in the Scopus database

    2-s2.0-85117496680